You are here

  • Home
  • Archive
  • Volume 21, Issue 6
  • Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects

Article info

Article menu
Download PDFPDF
Aetiology/Harm
Cohort study
Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects

Authors

  1. Correspondence to : Dr Ellen Løkkegaard, Department of Obstetrics and Gynaecology, North Zealand Hospital, University of Copenhagen, Dyrehavevej 29, Hillerød 3400, Denmark; Ellen.christine.leth.loekkegaard{at}regionh.dk
View Full Text

Citation

Løkkegaard E
Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects
BMJ Evidence-Based Medicine 2016;21:232.

Publication history

  • First published September 21, 2016.
Online issue publication 
November 21, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/